Higher Risks for Artificially Conceived Infants
By Miriam Zoll, <i>Biopolitical Times</i> guest contributor
| 03. 12. 2014
Data about the risks involved in high-tech assisted reproduction have until recently been scarce. The industry naturally touts success rates and downplays failures, and the Centers for Disease Control and Prevention (CDC) has largely been restricted to sharing only self-reported data from clinics with the public. But this is changing—and families intending to use these technologies should be aware of the full implications of the statistics that are available.
Last month, for instance, the Society for Assisted Reproductive Technologies announced that a record number of babies were born – 61,740 – as a result of the 165,172 in vitro fertilization (IVF) cycles performed at 379 of its member clinics in 2012.1
On the surface, this announcement may be perceived as an endorsement for the success of reproductive medical services that have, undoubtedly, helped many couples over the last 35 years to bear the children they might otherwise not have been able to. As we celebrate the births of these babies, however, it is also important to recognize that the vast majority of IVF cycles continue to fail, and that...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...